Cost of Atrial Fibrillation: Invasive vs Non-Invasive Management in 2012

Author(s): Yaariv Khaykin , Yana Shamiss .

Journal Name: Current Cardiology Reviews

Volume 8 , Issue 4 , 2012

Become EABM
Become Reviewer


Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It places an enormous burden on the patients, caregivers and the society at large. As a chronic illness, AF accrues significant costs related to clinical presentation, complications and loss of productivity. Novel invasive approaches to AF promise a cure in some patients and a significant reduction in AF burden in others, but are very expensive. This paper will address the cost of conventional and invasive strategies in AF care and will review the evidence on the comparative cost effectiveness of these approaches.

Keywords: Atrial fibrillation, catheter ablation, cost-effectiveness, aniarrhythmic therapy, antithrombotic therapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [368 - 373]
Pages: 6
DOI: 10.2174/157340312803760730
Price: $58

Article Metrics

PDF: 2